Breast MRI screening should be “strongly considered” for women with a personal history of breast cancer or high-risk lesions, according to new research published in Radiology.

Shanghai, China-based United Imaging Healthcare (UIH) has received FDA approval for its new PET/MR scanner.

The U.S. Nuclear Regulatory Commission (NRC) opened a 30-day public comment period seeking feedback on its draft document outlining training and experience requirements for administrating radiopharmaceuticals requiring a written directive.

The researchers analyzed the frequency and cancer yield of ACR Breast Imaging Reporting and Data System (BI-RADS) 3 lesions in patients who received baseline and non-baseline screening MRIs.

Short-interval follow-up MRI is an effective tool for identifying early-stage breast cancer, according to findings to be presented at the American Roentgen Ray Society (ARRS) 2019 Annual Meeting in Honolulu.

Providers should turn to ultrasound first, not mammography, when imaging palpable lumps after a mastectomy, according to new findings published in the American Journal of Roentgenology.

Peptide radionuclide therapy (PRRT) demonstrated long-term effectiveness in patients with malignant neuroendocrine tumors, reported authors of a study published in the Journal of Nuclear Medicine.

The joint statement—published in Thyroid—was put out by American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging and the European Thyroid Association.